A 6-month prospective trial of a personalized behavioral intervention + long-acting injectable antipsychotic in individuals with schizophrenia at risk for treatment non-adherence and homelessness

PURPOSE: Long-acting injectable antipsychotic medication (LAI) can optimize adherence for high-risk serious mental illness (SMI). This Customized Adherence Enhancement approach delivered by social worker interventionists was combined with LAI (CAE-L) of paliperidone palmitate for homeless, poorly-ad...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Psychopharmacol
Hauptverfasser: Sajatovic, Martha, Ramirez, Luis F., Fuentes-Casiano, Edna, Cage, Jamie, Tatsuoka, Curtis, Aebi, Michelle E., Bukach, Ashley, Cassidy, Kristin A., Levin, Jennifer B.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5678972/
https://ncbi.nlm.nih.gov/pubmed/28930768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000778
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge